NYSE - Delayed Quote USD

Koninklijke Philips N.V. (PHG)

26.57 -0.15 (-0.56%)
At close: August 31 at 4:00:02 PM EDT
26.76 +0.19 (+0.72%)
Pre-Market: 4:01:35 AM EDT
Trade PHG on Coinbase
Chart Range Bar
Loading chart for PHG
  • Previous Close 26.72
  • Open 26.72
  • Bid --
  • Ask --
  • Day's Range 26.54 - 26.76
  • 52 Week Range 23.85 - 33.44
  • Volume 631,427
  • Avg. Volume 1,094,851
  • Market Cap (intraday) 25.97B
  • Beta (5Y Monthly) 0.91
  • PE Ratio (TTM) 20.13
  • EPS (TTM) 1.32
  • Earnings Date Nov 3, 2026
  • Forward Dividend & Yield 1.01 (3.79%)
  • Ex-Dividend Date May 13, 2026
  • 1y Target Est 32.21

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

www.philips.com

63,670

Full Time Employees

December 31

Fiscal Year Ends

Performance Overview

Trailing total returns as of 9/1/2026, which may include dividends or other distributions. Benchmark is AEX-Index (^AEX) .

YTD Return

PHG
1.94%
AEX-Index (^AEX)
16.41%

1-Year Return

PHG
0.09%
AEX-Index (^AEX)
23.56%

3-Year Return

PHG
31.24%
AEX-Index (^AEX)
48.44%

5-Year Return

PHG
36.15%
AEX-Index (^AEX)
40.18%

Earnings Trends

View More

Earnings Per Share (Normalized)

 

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 4.36B
Earnings 384M
Profit Margin 8.81%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
1B
2B
3B
4B
5B
4.0%
5.0%
6.0%
7.0%
8.0%
 

Analyst Insights

View More

Analyst Price Targets

26.75
32.21 Average
26.57 Current
41.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Latest Rating

Date 8/3/2026
Analyst UBS
Rating Action Downgrade
Rating Neutral
Price Action --
Price Target --
 

Statistics

View More

Valuation Measures

Annual
As of 8/27/2026
  • Market Cap

    26.45B

  • Enterprise Value

    33.07B

  • Trailing P/E

    20.23

  • Forward P/E

    14.56

  • PEG Ratio (5yr expected)

    0.87

  • Price/Sales (ttm)

    1.26

  • Price/Book (mrq)

    1.97

  • Enterprise Value/Revenue

    1.61

  • Enterprise Value/EBITDA

    9.42

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.31%

  • Return on Assets (ttm)

    4.07%

  • Return on Equity (ttm)

    10.15%

  • Revenue (ttm)

    17.66B

  • Net Income Avi to Common (ttm)

    1.11B

  • Diluted EPS (ttm)

    1.32

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.79B

  • Total Debt/Equity (mrq)

    65.05%

  • Levered Free Cash Flow (ttm)

    1.53B

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

26.57 Current
 

Dividend Score

0 Low
Sector Avg.
100 High
 

Hiring Score

0 Low
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
Sector Avg.
100 High
 

Research Reports

View More
  • Philips Earnings: US Tariff Refund Lifts Headline Results, but Underlying Trends Weaken

    Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.

    Rating
    Price Target
     
  • Philips Sees Stable Demand and Mitigates Rising Input Costs Through Controls

    Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.

    Rating
    Price Target
     
  • Philips Earnings: Cost Control and Pricing Offset Rising Input Costs; Demand Stable

    Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.

    Rating
    Price Target
     
  • Philips Earnings: Strong Finish to 2025; Outlook Muted

    Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.

    Rating
    Price Target
     

People Also Watch